Betz Stephen F.
Officer at CRNX
- Sold, on record
- $8.7M
- Dollars the filings state
- Form 4 sales
- 48
- Latest Mar 16, 2026
- Form 144 notices
- 16
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CRNXCrinetics Pharmaceuticals, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CRNXRoutineAug 26, 2024 2024
Sold 3,000 shares at $53.19 ($160k)
Betz Stephen F., Chief Scientific Officer
10b5-1 planSold 4.1% of holdings ($3.9M position)69,611 shares left1x usual sizeFollows a Form 144Filing
- 2 Form 144 notice CRNXNoticeSep 10, 2024 +15 days
Filed to sell 1,035 shares ($53k)
Betz Stephen F., Officer, Co-Founder
10b5-1 plan0.3x usual sizeFiling
- 3 Form 4 sale CRNXRoutineSep 10, 2024 same day
Sold 1,035 shares at $51.50 ($53k)
Betz Stephen F., Chief Scientific Officer
10b5-1 planSold 1.5% of holdings ($3.6M position)68,576 shares left0.3x usual sizeFollows a Form 144Filing
- 4 Form 4 sale CRNXRoutineMar 19, 2025 +190 days
Sold 5,770 shares at $34.20 ($197k)
Betz Stephen F., Chief Scientific Officer
10b5-1 planSold 5% of holdings ($3.9M position)108,588 shares left1.9x usual sizeFiling
- 5 Form 144 notice CRNXNoticeJun 12, 2025 +85 days
Filed to sell 97,483 shares ($3.2M)
Betz Stephen F., Officer
10b5-1 plan32.5x usual sizeFiling
- 6 Form 4 sale CRNXUnusualJun 12, 2025 same day
Sold 97,483 shares at $32.23 ($3.1M)
Betz Stephen F., Chief Scientific Officer
10b5-1 planSold 49.4% of holdings ($6.4M position)99,713 shares left32.5x usual sizeFollows a Form 144Filing
- 7 Form 144 notice CRNXNoticeMar 16, 2026 +277 days
Filed to sell 26,525 shares ($994k)
Betz Stephen F., Officer
No 10b5-1 plan8.8x usual sizeFiling
- 8 Form 4 sale CRNXUnusualMar 16, 2026 same day
Sold 10,612 shares at $37.37 ($397k)
Betz Stephen F., Chief Scientific Officer
10b5-1 planSold 7.2% of holdings ($5.5M position)137,101 shares left3.5x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (64)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 18, 2026 | CRNX | Chief Scientific Officer | Form 4 sale | 10,612 | $397k | 7.2% | Unusual | SEC |
| Mar 16, 2026 | Mar 16, 2026 | CRNX | Officer | Form 144 notice | 26,525 | $994k | Notice | SEC | |
| Jun 12, 2025 | Jun 16, 2025 | CRNX | Chief Scientific Officer | Form 4 sale | 97,483 | $3.1M | 49.4% | Unusual | SEC |
| Jun 12, 2025 | Jun 12, 2025 | CRNX | Officer | Form 144 notice | 97,483 | $3.2M | Notice | SEC | |
| Mar 19, 2025 | Mar 21, 2025 | CRNX | Chief Scientific Officer | Form 4 sale | 5,770 | $197k | 5.0% | Routine | SEC |
| Sep 10, 2024 | Sep 12, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 1,035 | $53k | 1.5% | Routine | SEC |
| Sep 10, 2024 | Sep 10, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 1,035 | $53k | Notice | SEC | |
| Aug 26, 2024 | Aug 28, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $160k | 4.1% | Routine | SEC |
| Aug 26, 2024 | Aug 26, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $160k | Notice | SEC | |
| Aug 12, 2024 | Aug 14, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $143k | 4.0% | Routine | SEC |
| Aug 12, 2024 | Aug 12, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $143k | Notice | SEC | |
| Jul 25, 2024 | Jul 26, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $160k | 3.8% | Routine | SEC |
| Jul 25, 2024 | Jul 25, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $160k | Notice | SEC | |
| Jul 10, 2024 | Jul 12, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $146k | 3.7% | Routine | SEC |
| Jul 10, 2024 | Jul 10, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $146k | Notice | SEC | |
| Jun 25, 2024 | Jun 26, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $136k | 3.6% | Routine | SEC |
| Jun 25, 2024 | Jun 25, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $136k | Notice | SEC | |
| Jun 10, 2024 | Jun 11, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $132k | 3.5% | Routine | SEC |
| Jun 10, 2024 | Jun 10, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $132k | Notice | SEC | |
| May 28, 2024 | May 30, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $142k | 3.3% | Routine | SEC |
| May 28, 2024 | May 28, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $142k | Notice | SEC | |
| May 10, 2024 | May 14, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $148k | 3.2% | Routine | SEC |
| May 10, 2024 | May 10, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $148k | Notice | SEC | |
| Jan 25, 2024 | Jan 26, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $112k | 3.9% | Routine | SEC |
| Jan 25, 2024 | Jan 25, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $112k | Notice | SEC | |
| Jan 10, 2024 | Jan 12, 2024 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $113k | 3.8% | Routine | SEC |
| Jan 10, 2024 | Jan 10, 2024 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $113k | Notice | SEC | |
| Dec 26, 2023 | Dec 27, 2023 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $108k | 3.6% | Routine | SEC |
| Dec 26, 2023 | Dec 26, 2023 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $108k | Notice | SEC | |
| Dec 11, 2023 | Dec 13, 2023 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $99k | 3.5% | Routine | SEC |
| Dec 11, 2023 | Dec 11, 2023 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $99k | Notice | SEC | |
| Nov 27, 2023 | Nov 29, 2023 | CRNX | Chief Scientific Officer | Form 4 sale | 3,000 | $96k | 3.4% | Routine | SEC |
| Nov 27, 2023 | Nov 27, 2023 | CRNX | Officer, Co-Founder | Form 144 notice | 3,000 | $95k | Notice | SEC | |
| Feb 1, 2023 | Feb 3, 2023 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $61k | 4.6% | Plan not stated | SEC |
| Jan 25, 2023 | Jan 27, 2023 | CRNX | Chief Scientific Officer | Form 4 sale | 8,336 | $176k | 10.9% | Plan not stated | SEC |
| Jan 17, 2023 | Jan 19, 2023 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $56k | 3.9% | Plan not stated | SEC |
| Jan 3, 2023 | Jan 5, 2023 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $57k | 3.8% | Plan not stated | SEC |
| Dec 15, 2022 | Dec 19, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $50k | 3.7% | Plan not stated | SEC |
| Dec 1, 2022 | Dec 5, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $56k | 3.5% | Plan not stated | SEC |
| Nov 15, 2022 | Nov 17, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $59k | 3.4% | Plan not stated | SEC |
| Nov 1, 2022 | Nov 3, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $58k | 3.3% | Plan not stated | SEC |
| Oct 17, 2022 | Oct 19, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $55k | 3.2% | Plan not stated | SEC |
| Oct 3, 2022 | Oct 5, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $61k | 3.1% | Plan not stated | SEC |
| Sep 15, 2022 | Sep 19, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 4,168 | $88k | 4.0% | Plan not stated | SEC |
| Sep 7, 2022 | Sep 9, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 1,042 | $22k | 1.0% | Plan not stated | SEC |
| Sep 1, 2022 | Sep 6, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 3,126 | $58k | 2.9% | Plan not stated | SEC |
| May 2, 2022 | May 4, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 3,247 | $65k | 2.9% | Plan not stated | SEC |
| Apr 18, 2022 | Apr 21, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 5,664 | $146k | 4.9% | Plan not stated | SEC |
| Apr 4, 2022 | Apr 6, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 9,000 | $216k | 7.2% | Plan not stated | SEC |
| Apr 1, 2022 | Apr 1, 2022 | CRNX | Chief Scientific Officer | Form 4 sale | 8,328 | $178k | 6.2% | Plan not stated | SEC |